Physician profile
Chao Chen
NPI 1821010653
$601.56
in general payments reported to CMS, 2019-2025
10 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $37.63 · 2021: $16.66 · 2022: $24.25 · 2023: $17.01 · 2024: $172 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $185.60 | 2023-2025 | Airsupra, Breztri |
| Ucb, INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $89.41 | 2019-2025 | Shingrix, Penmenvy, Arexvy |
| Exact Sciences Corporation | $51.91 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $50.24 | 2024 | Mounjaro, Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.25 | 2022 | |
| Daiichi Sankyo INC. | $23.57 | 2020 | |
| Merck Sharp & Dohme LLC | $20.86 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Gilead Sciences, INC. | $16.66 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chao Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.